共 6 条
[1]
[2]
EASL Clinical Practice Guidelines: Management of chronic hepatitis B[J] European Association for the Study of the Liver Journal of Hepatology 2009,
[3]
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)[J] Gamal Shiha;Shiv Kumar Sarin;Alaa Eldin Ibrahim;Masao Omata;Ashish Kumar;Laurentius A. Lesmana;Nancy Leung;Nurdan Tozun;Saeed Hamid;Wasim Jafri;Hitoshi Maruyama;Pierre Bedossa;Massimo Pinzani;Yogesh Chawla;Gamal Esmat;Wahed Doss;Taher Elzanaty;Puja Sakhuja;Ahmed Medhat Nasr;Ashraf Omar;Chun-Tao Wai;Ahmed Abdallah;Mohsen Salama;Abdelkhalek Hamed;Ayman Yousry;Imam Waked;Medhat Elsahar;A
[4]
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update[J] Yun-Fan Liaw;Nancy Leung;Jia-Horng Kao;Teerha Piratvisuth;Edward Gane;Kwang-Hyub Han;Richard Guan;George K. K. Lau;Stephen Locarnini Hepatology International 2008,
[5]
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study[J] Yi-Cheng Chen;Chia-Ming Chu;Chau-Ting Yeh;Yun-Fan Liaw Hepatology International 2007,
[6]
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched; untreated cohort[J] Francis Y. Yao;Norah A. Terrault;Chris Freise;Lin Maslow;Nathan M. Bass Hepatology 2001,

